Lantern Pharma competitorsClear all

Lantern Pharma's top competitors include NexImmune, centrose, BenevolentAI and Paige.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Lantern Pharma
Lantern Pharma
Lantern Pharma is a biotechnology company developing precision cancer drugs.
NexImmune
NexImmune
NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform.
centrose
centrose
centrose is a biotechnology company engaged in the development and commercialization of antibody drug conjugates (ADCs), targeting disease-related cells.
BenevolentAI
BenevolentAI
BenevolentAI is a company that combines AI and machine learning with human expertise to discover new medicines.
Paige
Paige
Paige is a company that builds computational technologies to transform the diagnosis, treatment, biomarker discovery, and drug development for cancer.
Founding Date
Founding Date
2013
Founding Date
2011
Founding Date
2007
Founding Date
2013
Founding Date
2018
Type
Type
Public
Type
Public
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Dallas, US HQ
Locations
Gaithersburg, US HQ
Locations
Middleton, US HQ
Locations
London, GB HQ
Babraham, GB
New York, US
Locations
New York, US HQ
Employees
Employees
12200% increase
Employees
452% increase
Employees
N/A
Employees
3171% decrease
Employees
1294% increase
Valuation ($)
Valuation ($)
108.4 m
Valuation ($)
255.2 m
Valuation ($)
N/A
Valuation ($)
1 b
Valuation ($)
N/A
Twitter followers
Twitter followers
381
Twitter followers
40
Twitter followers
9
Twitter followers
7.2 k
Twitter followers
1.6 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
18
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
26
Number of tweets (last 30 days)
10
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
3.9
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
3.9
Average likes per tweet (last 30 days)
5.7
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
83.33%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
92.31%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
344155
Alexa Website Rank
217336
Alexa Website Rank
N/A
Alexa Website Rank
315687
Alexa Website Rank
N/A
Employee Rating
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
4.8
Employee Rating
4.7

Financial

Net income
Net income
($5.9m) (FY, 2020)
Net income
($20.5m) (FY, 2019)
Net income
N/A
Net income
(£26.9m) (FY, 2018)
Net income
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 100k (almost 8 years ago)
Latest funding round
$ 90m (about 2 years ago)
Latest funding round
$ 25m (9 months ago)
Total funding raised
Total funding raised
$ 4.7m
Total funding raised
$ 33.8m
Total funding raised
$ 100k
Total funding raised
$ 305m
Total funding raised
$ 220m
For sources of this data, please see the company profile

View company profiles

NexImmune
HQ
Gaithersburg, US
Employees
45↑ 2% increase

NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform.

View company
centrose
HQ
Middleton, US

centrose is a biotechnology company engaged in the development and commercialization of antibody drug conjugates (ADCs), targeting disease-related cells.

View company
BenevolentAI
HQ
London, GB
Employees
317↓ 1% decrease

BenevolentAI is a company that combines AI and machine learning with human expertise to discover new medicines.

View company
Paige
HQ
New York, US
Employees
129↑ 4% increase

Paige is a company that builds computational technologies to transform the diagnosis, treatment, biomarker discovery, and drug development for cancer.

View company